BE2016C017I2 - - Google Patents

Download PDF

Info

Publication number
BE2016C017I2
BE2016C017I2 BE2016C017C BE2016C017C BE2016C017I2 BE 2016C017 I2 BE2016C017 I2 BE 2016C017I2 BE 2016C017 C BE2016C017 C BE 2016C017C BE 2016C017 C BE2016C017 C BE 2016C017C BE 2016C017 I2 BE2016C017 I2 BE 2016C017I2
Authority
BE
Belgium
Prior art keywords
salmeterol
budesonide
solvate
component
salt
Prior art date
Application number
BE2016C017C
Other languages
English (en)
French (fr)
Original Assignee
Galephar M/F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galephar M/F filed Critical Galephar M/F
Publication of BE2016C017I2 publication Critical patent/BE2016C017I2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE2016C017C 2001-08-07 2016-04-06 BE2016C017I2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE0100132 2001-08-07
PCT/BE2002/000132 WO2003013547A1 (en) 2001-08-07 2002-07-31 Pharmaceutical composition comprising salmeterol and budesonide for the treatment of respiratory disorders

Publications (1)

Publication Number Publication Date
BE2016C017I2 true BE2016C017I2 (es) 2021-07-19

Family

ID=50036776

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2016C017C BE2016C017I2 (es) 2001-08-07 2016-04-06

Country Status (8)

Country Link
US (2) US20040247530A1 (es)
EP (1) EP1414468B1 (es)
AT (1) ATE284696T1 (es)
BE (1) BE2016C017I2 (es)
CA (1) CA2456721C (es)
DE (1) DE60202299T2 (es)
ES (1) ES2232769T3 (es)
WO (1) WO2003013547A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040191176A1 (en) * 2003-03-28 2004-09-30 Kaplan Leonard W Formulations for treatment of pulmonary disorders
SE527069C2 (sv) 2003-06-19 2005-12-13 Mederio Ag Förfarande och anordning för administrering av läkemedelspulver
CN110237260A (zh) * 2010-07-16 2019-09-17 希普拉有限公司 包含r(+)布地奈德和一种或多种支气管扩张剂的药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009613D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
CA2417973A1 (en) * 2000-08-04 2002-02-14 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration

Also Published As

Publication number Publication date
ES2232769T3 (es) 2005-06-01
CA2456721A1 (en) 2003-02-20
US20040247530A1 (en) 2004-12-09
CA2456721C (en) 2012-03-20
DE60202299D1 (de) 2005-01-20
DE60202299T2 (de) 2005-12-08
US20080107740A1 (en) 2008-05-08
ATE284696T1 (de) 2005-01-15
EP1414468B1 (en) 2004-12-15
EP1414468A1 (en) 2004-05-06
WO2003013547A1 (en) 2003-02-20

Similar Documents

Publication Publication Date Title
WO2007009806A3 (en) Solid dosage formulations of narcotic drugs having improved buccal adsorption
ES2178943A1 (es) Uso de compuestos organicos en el tratamiento de enfermedad pulmonar obstructiva cronica.
AP1818A (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
HK1065483A1 (en) 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives
TR199500856A2 (tr) Nefesle ice cekilerek alinan farmasötik bilesim.
CA2334411A1 (en) Use of a composition comprising formoterol and budesonide for the prevention or treatment of an acute condition of asthma
EP1283054A4 (en) MEDICAMENTS FOR TREATING THE COMPLICATIONS OF DIABETES AND NEUROPATHIES AND USE THEREOF
MXPA04004779A (es) Inhibidores de 11-beta-hidroxiesteroide deshidrogenasa de tipo 1.
CA2258095A1 (en) Tetrahydrolipstatin containing compositions
WO2004030611A3 (en) Non-nucleoside reverse transcriptase inhibitors
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
WO2002030467A3 (en) Pharmaceutical composition containing honey for the treatment of wounds
SE0102440D0 (sv) New compound
BE2016C017I2 (es)
EP2138175A3 (en) Formulations comprising valsartan for treating diabetes or microalbuminuria
WO1999061010A3 (en) Treatment of infertility with cam-increasing compounds alone or in combination with at least one meiosis-stimulating compound
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
TNSN06072A1 (en) Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
AU2173101A (en) Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents
WO2000066550A8 (en) New compounds
SE0000303D0 (sv) Novel compounds
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.
MXPA02006034A (es) Formas de dosis mucosaloral de apomorfina.
WO2004033484A3 (en) Use of stable glutamine derivatives to improve drug absorption